Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-2.69%
1,068.24
-29.57
-2.69%
—1,097.811,087.761,087.761,067.42——
SIXC
Communications
SIXC
Communications
SIXC
-0.89%
606.59
-5.44
-0.89%
—612.03612.03612.03606.13——
SIXE
Energy
SIXE
Energy
SIXE
+2.19%
1,247.21
+26.78
+2.19%
—1,220.431,221.991,247.601,221.99——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.82%
1,727.58
-31.94
-1.82%
—1,759.521,754.311,754.311,723.60——
SIXM
Financials
SIXM
Financials
SIXM
-0.32%
629.54
-2.00
-0.32%
—631.54631.27633.99628.63——
SIXR
Staples
SIXR
Staples
SIXR
-0.42%
853.60
-3.56
-0.42%
—857.16858.91861.71852.33——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.56%
212.04
-3.37
-1.56%
—215.41215.41215.41211.88——
SIXT
Technology
SIXT
Technology
SIXT
-1.78%
3,549.76
-64.39
-1.78%
—3,614.153,556.243,598.363,516.86——
SIXU
Utilities
SIXU
Utilities
SIXU
-2.40%
886.49
-21.81
-2.40%
—908.30906.55906.55885.88——
SIXV
Health care
SIXV
Health care
SIXV
-1.08%
1,464.34
-16.06
-1.08%
—1,480.401,479.551,484.431,462.52——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.84%
2,354.25
-44.12
-1.84%
—2,398.372,373.092,373.092,350.27——
AXGN:NASDAQ
AxoGen, Inc Common Stock
$40.99
+0.10%
(+0.040) 1D
$40.99
0.00% (0.00)
After hours
Closed: May 15, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AXGN...
Open
$40.74
High
$41.60
Low
$40.39
Mkt. cap
2.18B
Avg. vol.
1.11M
Volume
1.03M
52-wk high
$45.75
52-wk low
$9.22
EPS
-$0.64
Beta
1.17
Shares outstanding
53.18M
No. of employees
622
News stories
From sources across the web
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersAlachua, Florida, United States
SectorMedical device
Websiteaxogeninc.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
56.66M
60.08M
59.90M
61.46M
Cost of goods sold
14.64M
14.09M
15.50M
15.27M
Cost of revenue
14.64M
14.09M
15.50M
15.27M
Research and development expenses
6.85M
7.56M
12.38M
7.52M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.49M
36.52M
41.80M
41.50M
Operating expense
40.35M
44.08M
54.18M
49.02M
Total operating expenses
54.99M
58.17M
69.68M
64.29M
Operating income
1.67M
1.91M
-9.77M
-2.83M
Other non operating income
659.00K
234.00K
-2.02M
23.00K
EBT including unusual items
579.00K
708.00K
-13.16M
-19.58M
EBT excluding unusual items
579.00K
708.00K
-13.16M
-2.74M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
579.00K
708.00K
-13.16M
-19.58M
Net profit margin
1.02%
1.18%
-21.96%
-31.87%
Earnings per share
0.12
0.12
0.07
0.07
Interest and investment income
225.00K
319.00K
352.00K
768.00K
Interest expense
-1.98M
-1.76M
-1.72M
-694.00K
Net interest expenses
-1.75M
-1.44M
-1.37M
74.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
3.40M
3.64M
-8.04M
-1.13M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer